Open AccessA patient with relapsed high-grade serous ovarian carcinoma with somatic RAD51C mutations treated with PARPi monotherapy: a case report
Author(s) -
Siew Fei Ngu,
Hextan Ys Ngan,
Karen K. L. Chan
Publication year - 2022
Publication title -
cancer drug resistance
Language(s) - English
Resource type - Journals
ISSN - 2578-532X
DOI - 10.20517/cdr.2022.12
Subject(s) - medicine , olaparib , ovarian cancer , ovarian carcinoma , chemotherapy , oncology , serous fluid , serous carcinoma , radiology , cancer , biochemistry , chemistry , polymerase , poly adp ribose polymerase , gene